Delivery Order SPE2DB22D3501-SPE2DB25FXN62
Award Date 9/26/25
Potential Completion Date 9/29/25
Potential Value $1.2K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- AmerisourceBergen Drug Corp was awarded a delivery order contract by the Defense Logistics Agency (DLA) on August 8, 2025, for the supply of Doxorubicin Liposome 50mg/25ml in 25ml units, with a ceiling value of $1,796.98. The contract is a firm fixed-price delivery order with an ultimate completion date of August 11, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. This award was competitively awarded without set-aside designation. This delivery order is...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of the global pharmaceutical distribution company AmerisourceBergen Corporation. The $5,400.00 fixed-price delivery order is for the supply of 4,564,081,943 units of Doxorubicin Liposome 20mg/10ml 10ml, a specialty pharmaceutical product, with a performance period through March 27, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up...
- This is a $1,500 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on January 30, 2024. The contract is for the delivery of 50mg/25ml doxorubicin liposome, a specialty medication, with a performance period ending January 31, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 between DLA Troop Support Medical and AmerisourceBergen, which provides a...
- This federal contract award to Amerisourcebergen Drug Corp is a Delivery Order valued at $1,500.00 for the supply of Doxorubicin Liposome 50mg/25ml, a specialty pharmaceutical product. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of January 31, 2024. This Delivery Order is issued under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued at $999,999,999 and running through November 2026....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Doxorubicin 200 mg/100 mL vials totaling $1,928.51 with a firm fixed price arrangement. The contract, which is non-set-aside and competitively awarded, was finalized on July 22, 2025, with an ultimate completion date of July 23, 2025. Performance will occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under...
- This federal contract award is for the delivery of Doxorubicin Liposome 50mg/25ml pharmaceutical products, awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $7,485.80 Firm Fixed Price Delivery Order has a completion date of May 3, 2024. The contract is not designated with a set-aside. Amerisourcebergen Drug Corp, a major pharmaceutical distributor, has a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award, identified as SPE2DB20D3103|SPE2DB24FM6D7, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,500.00 firm fixed-price delivery order is for the supply of Doxorubicin Liposome 50mg/25ml, a specialty medication. The contract is not designated with a set-aside, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which also holds...
- The Defense Logistics Agency awarded a $714 delivery order to Amerisourcebergen Drug Corporation for doxorubicin hydrochloride injection. The product will be delivered from the contractor's facility in Conshohocken, Pennsylvania to an unknown customer by July 14, 2023. The firm fixed price order was issued under an unspecified multiple award contract vehicle. No subcontractors or set aside designations were indicated. The Defense Logistics Agency manages the global supply chain for the United...
- The U.S. Department of Defense's Defense Logistics Agency (DLA) Troop Support Medical awarded a Delivery Order contract worth $1,726.81 to Amerisourcebergen Drug Corp's Corporate Office Division for the supply of 50 mg Doxorubicin vials. This Delivery Order contract is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025. Under this IDC, Amerisourcebergen provides a comprehensive range of pharmaceutical...
- The Defense Logistics Agency awarded a $2,550.00 firm fixed price delivery order to AmerisourceBergen Drug Corp for Dactinomycin 500 microgram vials, with an ultimate completion date of September 18, 2025. This non-set-aside delivery order represents a competitive award to support federal medical procurement needs. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor and healthcare solutions provider for military and veteran...